Does Late Melatonin Release Affect ADHD? 

Yes, late melatonin ADHD release can significantly affect individuals with ADHD. Melatonin is a sleep hormone that regulates the body’s sleep-wake cycle. In people with ADHD, the timing of melatonin release may be delayed, causing issues with falling asleep at a regular time. This misalignment of the sleep cycle can worsen ADHD symptoms, such as inattention, irritability, and emotional dysregulation. 

How Late Melatonin Release Affects ADHD 

Typically, melatonin is released in response to darkness, helping to signal the body that it’s time to wind down. However, for individuals with ADHD, the production of melatonin may be delayed, which means they may not feel sleepy until much later than typical. This delay in melatonin release can lead to inconsistent sleep schedules, making it difficult to wake up on time and feel rested, and sleep deprivation, which can worsen daytime ADHD symptoms like focus difficulties, impulsivity, mood swings, difficulty transitioning to bedtime, as the brain’s sleep signals don’t align with the body’s needs. 

Managing Late Melatonin Release in ADHD 

If melatonin ADHD levels are consistently delayed, interventions like melatonin supplements taken in the evening or light therapy in the morning can help shift the body’s internal clock. Good sleep hygiene practices, such as avoiding screens before bed, are also crucial for improving sleep quality. 

Recognising how late melatonin release affects ADHD allows for better treatment strategies, helping improve both sleep and ADHD symptom management.For more on melatonin, ADHD, and sleep-related challenges, reach out to providers like ADHD Certify.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Sleep disorders. 

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.